Emerging Data for Venetoclax in Chronic Lymphocytic Leukemia

被引：0
|
作者：
O'Brien, Susan M. [1 ]
机构：
[1] Univ Calif Irvine, Med, Div Hematol Oncol, Orange, CA 92668 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2022年 / 20卷 / 03期
关键词：
IBRUTINIB; ZANUBRUTINIB; CHLORAMBUCIL; OBINUTUZUMAB; RITUXIMAB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 183
页数：6
相关论文
共 50 条
  • [1] Venetoclax for the treatment of chronic lymphocytic leukemia
    Gentile, Massimo
    Petrungaro, Annamaria
    Uccello, Giuseppina
    Vigna, Ernesto
    Recchia, Anna Grazia
    Caruso, Nadia
    Bossio, Sabrina
    De Stefano, Laura
    Palummo, Angela
    Storino, Francesca
    Martino, Massimo
    Morabito, Fortunato
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1307 - 1316
  • [2] Venetoclax in the treatment of chronic lymphocytic leukemia
    Korycka-Wolowiec, Anna
    Wolowiec, Dariusz
    Kubiak-Mlonka, Aleksandra
    Robak, Tadeusz
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 353 - 366
  • [3] Venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Fischer, Kirsten
    Al-Sawaf, Othman
    Fink, Anna-Maria
    Dixon, Mark
    Bahlo, Jasmin
    Warburton, Simon
    Kipps, Thomas J.
    Weinkove, Robert
    Robinson, Sue
    Seiler, Till
    Opat, Stephen
    Owen, Carolyn
    Lopez, Javier
    Humphrey, Kathryn
    Humerickhouse, Rod
    Tausch, Eugen
    Frenzel, Lukas
    Eichhorst, Barbara
    Wendtner, Clemens-M.
    Stilgenbauer, Stephan
    Langerak, Anton W.
    van Dongen, Jacque J. M.
    Boettcher, Sebastian
    Ritgen, Matthias
    Goede, Valentin
    Mobasher, Mehrdad
    Hallek, Michael
    [J]. BLOOD, 2017, 129 (19) : 2702 - 2705
  • [4] Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
    Herbert Eradat
    [J]. Current Hematologic Malignancy Reports, 2019, 14 : 469 - 476
  • [5] Venetoclax (Venclexta) for Chronic Lymphocytic Leukemia
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1500): : 101 - 102
  • [6] Venetoclax for the Treatment of Chronic Lymphocytic Leukemia
    Eradat, Herbert
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (05) : 469 - 476
  • [7] Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia
    Molica, Stefano
    Allsup, David
    Gianfelici, Valentina
    Levato, Luciano
    Aiello, Vincenzo
    Bailey, James
    Polliack, Aaron
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (06) : 621 - 633
  • [8] Venetoclax for the treatment of patients with chronic lymphocytic leukemia
    Crombie, Jennifer
    Davids, Matthew S.
    [J]. FUTURE ONCOLOGY, 2017, 13 (14) : 1223 - 1232
  • [9] An update on the efficacy of Venetoclax for chronic lymphocytic leukemia
    Lovell, Alexandra R.
    Sawyers, Jacki
    Bose, Prithviraj
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (11) : 1307 - 1316
  • [10] Venetoclax Approved for Use in Chronic Lymphocytic Leukemia
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (05) : 339 - 339
12345